Spire Wealth Management’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed -$63K 2348
2022
Q2
$63K Hold
1
﹤0.01% 1198
2022
Q1
$102K Hold
1
﹤0.01% 1154
2021
Q4
$52K Hold
1
﹤0.01% 1705
2021
Q3
$67K Hold
1
﹤0.01% 1357
2021
Q2
$84K Hold
1
﹤0.01% 1251
2021
Q1
$108K Buy
+1
New +$220K ﹤0.01% 1370

Other funds holding GNPX

Spire Wealth Management's GNPX Position: Q3 2022 in Review

Spire Wealth Management sold out of Genprex (GNPX) in Q3 2022, closing a stake of 1 share — an estimated $63K sold.

Spire Wealth Management first reported a position in GNPX in Q1 2021 and held it in 6 quarters. The position peaked at $108K in Q1 2021. 19 funds tracked by Wall St. Rank hold GNPX as of Q3 2022.

  • Spire Wealth Management reported no remaining Genprex position as of Q3 2022 after selling out during the quarter.
  • Spire Wealth Management sold 1 Genprex share in Q3 2022, an estimated $63K.
  • Spire Wealth Management first reported a position in Genprex in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's Genprex position peaked at $108K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Genprex as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.